Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ICHNO-ECHNO 2022 | Potential of immunotherapy in head and neck cancer

Kevin Harrington, FRCP, FRCR, FRSB, PhD, The Institute of Cancer Research and Royal Marsden Hospital, London, UK, discusses the promising future of immunotherapy for patients with head and neck cancer. Prof. Harrington suggests that immunotherapy has the potential to provide curative treatment for some patients, but there is a lot more research to be done, such as studying why some patients have resistance to immunotherapy, what treatment schedule is best, and what combination therapies could achieve maximum benefit for patients. This interview took place at the joint International Congress on Innovative Approaches in Head and Neck Oncology and the European Congress on Head and Neck Oncology (ICHNO-ECHNO) 2022 hybrid meeting in Brussels, Belgium.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.